Average Co-Inventor Count = 5.75
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nerviano Medical Sciences S.r.l. (22 from 138 patents)
2. Ignyta, Inc. (3 from 25 patents)
3. Farmitalia Carlo Erba S.r.l. (2 from 140 patents)
4. Pharmacia S.p.a. (2 from 20 patents)
5. Pharmacia & Upjohn S.p.a. (1 from 97 patents)
6. Pfizer Italia S.r.l. (1 from 23 patents)
28 patents:
1. 10682348 - Molecules for administration to ROS1 mutant cancer cells
2. 10561651 - Methods for treating neuroblastoma
3. 10231965 - Molecules for administration to ROS1 mutant cancer cells
4. 10221181 - 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
5. 10081622 - Substituted indazole derivatives active as kinase inhibitors
6. 9682083 - Pyrrolo[2,3-D]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
7. 9670191 - Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
8. 9616059 - Substituted indazole derivatives active as kinase inhibitors
9. 9604980 - Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
10. 9255087 - Substituted indazole derivatives active as kinase inhibitors
11. 9102662 - Substituted indazole derivatives active as kinase inhibitors
12. 9085558 - Substituted indazole derivatives active as kinase inhibitors
13. 9056854 - Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
14. 9029356 - Substituted indazole derivatives active as kinase inhibitors
15. 8906934 - Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors